Physician profile
David J Henson
NPI 1801899224
$2,133.16
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,820 · 2020: $297 · 2023: $16.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $400.57 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $300.07 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $265.18 | 2019 | |
| Sunovion Pharmaceuticals INC. | $234.22 | 2019-2020 | |
| Genentech, INC. | $159.80 | 2019 | |
| Jazz Pharmaceuticals INC. | $93.55 | 2019-2020 | |
| Grifols USA, LLC | $81.38 | 2019 | |
| Shire North American Group INC | $78.71 | 2019 | |
| Mylan Specialty L.P. | $68.37 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $63.93 | 2019-2020 | |
| Philips North America LLC | $63.05 | 2019-2020 | |
| Insmed, INC. | $49.61 | 2020-2023 | Arikayce |
| Merck Sharp & Dohme LLC | $44.88 | 2019 | |
| Genentech USA, INC. | $44.10 | 2019-2020 | |
| Electromed, INC. | $39.41 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $38.76 | 2019 | |
| Pulmonx Corporation | $20.04 | 2019 | |
| Portola Pharmaceuticals, LLC | $19.82 | 2020 | |
| Advanced Respiratory, INC | $19.78 | 2020 | |
| Covidien LP | $19.06 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $16.31 | 2020 | |
| Circassia INC. | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Henson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.